Lumida
/CRL
⌘K
Charles River Laboratories International Inc

Charles River Laboratories International Inc

CRL
$278.35USD-0.86%-2.41 today

MARKET CAP

13.3B

P/E (TTM)

29.1x

FWD P/E

23.1x

DAY RANGE

$275 – $281

52W RANGE

$144
$303

AI Summary

Stalk
Sell NowMedium

CRL has decisively broken key short-term support and the 20-day EMA in a Stage 3 distribution phase, establishing a medium-term bearish bias. Short-term conditions favor selling now as price rejects at the 9EMA and 20EMA with no visible exhaustion, targeting further downside toward secondary support near the 50-day SMA if the breakdown holds.

  • Q2 revenue $1B (+8.98% YoY) beats $980.5M forecast
  • Q2 EPS $3.02 vs. $2.77 consensus, fourth straight beat
  • Negative growth indicators point to possible revenue stalls
Full analysis →

No politician trades found for CRL.